hydroxyflutamide has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farla, P; Hersmus, R; Houtsmuller, AB; Trapman, J | 1 |
| Gaido, KW; Maness, SC; McDonnell, DP | 1 |
2 other study(ies) available for hydroxyflutamide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Antiandrogens prevent stable DNA-binding of the androgen receptor.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Computer Simulation; DNA; DNA-Binding Proteins; DNA, Neoplasm; Flutamide; Green Fluorescent Proteins; Humans; Liver Neoplasms; Male; Metribolone; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Recombinant Fusion Proteins; Tosyl Compounds | 2005 |
Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; DDT; Dihydrotestosterone; Estradiol; Flutamide; Humans; Insecticides; Isomerism; Methoxychlor; Progesterone; Receptors, Androgen; Testosterone; Transcription, Genetic; Tumor Cells, Cultured | 1998 |